International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update.
In this review we attempt to summarize experimental evidence on the existence of defined native GABA(A) receptor subtypes and to produce a list of receptors that actually seem to exist according to current knowledge. This will serve to update the most recent classification of GABA(A) receptors (Pharmacol Rev 50:291-313, 1998) approved by the Nomenclature Committee of the International Union of Pharmacology. GABA(A) receptors are chloride channels that mediate the major form of fast inhibitory neurotransmission in the central nervous system. They are members of the Cys-loop pentameric ligand-gated ion channel (LGIC) superfamily and share structural and functional homology with other members of that family. GABA(A) receptors are assembled from a family of 19 homologous subunit gene products and form numerous, mostly hetero-oligomeric, pentamers. Such receptor subtypes with properties that depend on subunit composition vary in topography and ontogeny, in cellular and subcellular localization, in their role in brain circuits and behaviors, in their mechanisms of regulation, and in their pharmacology. We propose several criteria, which can be applied to all the members of the LGIC superfamily, for including a receptor subtype on a list of native hetero-oligomeric subtypes. With these criteria, we develop a working GABA(A) receptor list, which currently includes 26 members, but will undoubtedly be modified and grow as information expands. The list is divided into three categories of native receptor subtypes: "identified," "existence with high probability," and "tentative."
Olsen
Richard W
RW
Department of Molecular and Medical Pharmacology, Geffen School of Medicine at UCLA, Room CHS 23-120, 650 Young Drive South, Los Angeles, CA 90095-1735, USA. rolsen@mednet.ucla.edu
Sieghart
Werner
W
D000818:Animals; D002490:Central Nervous System / Q000378:metabolism; D006801:Humans; D008024:Ligands; D011487:Protein Conformation; D021122:Protein Subunits / Q000145:classification* / Q000378:metabolism; D011963:Receptors, GABA-A / Q000145:classification* / Q000235:genetics / Q000378:metabolism; D009626:Terminology as Topic
D008024:Ligands; D021122:Protein Subunits; D011963:Receptors, GABA-A
Pharmacol Rev. 1998 Jun;50(2):291-313
9647870
Mol Pharmacol. 1994 Jun;45(6):1061-70
8022401
Proc Natl Acad Sci U S A. 2005 Nov 22;102(47):17154-9
16284244
Trends Pharmacol Sci. 2005 Nov;26(11):587-94
16194573
Mol Cell Neurosci. 2008 Mar;37(3):610-21
18206389
Neuroscience. 1991;42(2):497-507
1654537
J Neurosci. 2005 Dec 14;25(50):11513-20
16354909
Neuropharmacology. 1996;35(9-10):1425-44
9014159
Pharmacol Rev. 2001 Mar;53(1):107-18
11171941
Neuroreport. 1996 Mar 22;7(4):943-7
8724679
Br J Pharmacol. 2002 Aug;136(7):965-74
12145096
Br J Pharmacol. 2004 May;142(1):97-106
15100159
J Neurochem. 2003 Dec;87(6):1444-55
14713300
Mol Pharmacol. 2008 Mar;73(3):960-7
18079275
J Neurosci. 2005 Dec 7;25(49):11219-30
16339017
Mol Pharmacol. 1992 Jan;41(1):89-103
1370710
J Pharmacol Exp Ther. 2006 Jan;316(1):410-22
16183706
J Neurosci. 2001 May 15;21(10):3409-18
11331371
Pharmacol Rev. 2007 Mar;59(1):5-13
17329545
Curr Pharm Des. 2007;13(31):3169-77
18045166
Mol Neurobiol. 2007 Feb;35(1):113-28
17519509
Trends Neurosci. 2004 May;27(5):262-9
15111008
J Neurosci. 2006 Feb 8;26(6):1749-58
16467523
Prog Neurobiol. 2002 Jun;67(2):113-59
12126658
Curr Opin Neurobiol. 2003 Jun;13(3):341-7
12850219
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8546-51
16581914
Alcohol Clin Exp Res. 2008 Jan;32(1):19-26
18070250
J Neurochem. 2007 Jul;102(2):479-92
17419810
J Neurosci. 1994 Nov;14(11 Pt 2):7168-79
7965107
J Biol Chem. 2002 Nov 29;277(48):46020-5
12324466
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9891-6
10449790
Annu Rev Pharmacol Toxicol. 2004;44:475-98
14744255
J Neurosci. 1998 Mar 1;18(5):1693-703
9464994
Biochem Pharmacol. 2004 Oct 15;68(8):1581-602
15451402
J Biol Chem. 1991 Mar 5;266(7):4478-83
1847922
J Pharmacol Exp Ther. 2004 Nov;311(2):601-9
15210837
Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):15218-23
14625373
J Neurosci. 2004 Aug 18;24(33):7241-50
15317850
J Neurosci. 1997 Oct 15;17(20):7662-72
9315888
J Neurosci. 2003 May 1;23(9):3649-57
12736336
J Biol Chem. 1995 Nov 3;270(44):26063-6
7592805
Eur J Neurosci. 1999 Jan;11(1):41-50
9987010
Mol Pharmacol. 2005 Oct;68(4):942-51
16027231
Neuropharmacology. 1997 Nov-Dec;36(11-12):1641-52
9517435
Br J Pharmacol. 2006 Apr;147(8):839-53
16474411
Mol Pharmacol. 2001 Apr;59(4):814-24
11259626
J Physiol. 2007 Jun 15;581(Pt 3):1001-18
17395622
J Pharmacol Exp Ther. 2006 Mar;316(3):1335-45
16326923
J Comp Neurol. 2002 Apr 29;446(2):179-97
11932935
J Biol Chem. 1999 Jul 9;274(28):19613-6
10391897
J Biol Chem. 2001 Mar 30;276(13):10532-8
11136737
J Neurosci. 1997 Feb 15;17(4):1350-62
9006978
Neuroscience. 2002;111(3):657-69
12031352
Curr Top Med Chem. 2002 Aug;2(8):795-816
12171572
Proc Natl Acad Sci U S A. 1997 Sep 30;94(20):11031-6
9380754
Trends Pharmacol Sci. 2005 Oct;26(10):503-10
16126282
J Neurosci. 2002 Apr 1;22(7):2513-21
11923416
J Physiol. 2001 Nov 1;536(Pt 3):785-96
11691872
J Neurosci. 1992 Nov;12(11):4151-72
1331359
Br J Pharmacol. 1999 Jul;127(6):1349-58
10455284
Br J Pharmacol. 1997 Mar;120(5):749-56
9138677
Proc Natl Acad Sci U S A. 2004 Mar 9;101(10):3662-7
14993607
Mol Pharmacol. 2006 Feb;69(2):640-9
16272224
Eur J Neurosci. 2006 May;23(9):2495-504
16706856
Science. 2000 Oct 6;290(5489):131-4
11021797
EMBO J. 1992 Jun;11(6):2017-23
1376242
J Neurosci. 2000 May 15;20(10):3588-95
10804200
Nat Neurosci. 2005 Mar;8(3):339-45
15696164
Mol Pharmacol. 1993 Dec;44(6):1211-8
8264558
J Biol Chem. 1994 Oct 14;269(41):25777-82
7929282
J Physiol. 2001 Nov 15;537(Pt 1):101-13
11711565
Mol Neurobiol. 1998 Aug;18(1):35-86
9824848
Pharmacol Rev. 2002 Jun;54(2):247-64
12037141
J Neurosci. 1997 Jul 1;17(13):5027-37
9185540
RNA. 2007 May;13(5):698-703
17369310
J Neurosci. 2006 Apr 5;26(14):3713-20
16597725
J Mol Biol. 2005 Mar 4;346(4):967-89
15701510
J Chem Neuroanat. 1990 Jan-Feb;3(1):59-76
2156526
J Neurosci. 2006 Aug 2;26(31):8017-20
16885215
Nature. 2001 May 17;411(6835):269-76
11357122
Eur J Neurosci. 2000 Sep;12(9):3137-45
10998097
J Physiol. 2005 Jan 1;562(Pt 1):27-36
15528236
J Comp Neurol. 1995 Aug 14;359(1):154-94
8557845
Pharmacol Biochem Behav. 2000 Jun;66(2):371-4
10880692
Nature. 2003 Jun 26;423(6943):949-55
12827192
Expert Opin Investig Drugs. 2005 May;14(5):601-18
15926867
FASEB J. 2003 Feb;17(2):250-2
12475885
Proc Natl Acad Sci U S A. 2006 Oct 10;103(41):15230-5
17005728
Nat Neurosci. 2000 Nov;3(11):1059
11036253
Annu Rev Pharmacol Toxicol. 2000;40:431-58
10836143
Trends Pharmacol Sci. 1997 Nov;18(11):425-9
9426470
Trends Pharmacol Sci. 1995 May;16(5):162-8
7624971
Proc Natl Acad Sci U S A. 1994 May 10;91(10):4569-73
8183949
Nat Rev Neurosci. 2002 Sep;3(9):728-39
12209121
Trends Pharmacol Sci. 1989 Oct;10(10):407-11
2559519
Proc Natl Acad Sci U S A. 1995 Aug 15;92(17):7749-53
7644489
Nature. 2006 Aug 3;442(7102):527-32
16885977
J Biol Chem. 1994 Apr 29;269(17):12993-8
8175718
Eur J Pharmacol. 2004 Aug 23;497(2):139-46
15306198
J Neurosci. 2002 Mar 1;22(5):1541-9
11880484
J Neurochem. 2007 Jul;102(1):1-12
17394533
J Recept Res. 1991;11(1-4):535-51
1653350
J Neurochem. 2006 Jan;96(1):136-47
16277610
J Physiol. 2008 Feb 15;586(4):989-1004
18079158
Br J Pharmacol. 1996 Feb;117(3):521-527
8821543
Eur J Neurosci. 2000 Dec;12(12):4318-30
11122342
J Neurochem. 1994 Oct;63(4):1466-76
7931299
J Biol Chem. 1997 Jun 13;272(24):15346-50
9182563
Proc Natl Acad Sci U S A. 2004 May 18;101(20):7769-74
15136735
Annu Rev Neurosci. 1994;17:569-602
7516126
Mol Pharmacol. 2005 Nov;68(5):1291-300
16103045
J Physiol. 2004 Sep 1;559(Pt 2):355-65
15235089
J Neurosci. 2005 Nov 16;25(46):10682-8
16291941
Biochem Soc Trans. 2006 Nov;34(Pt 5):868-71
17052217
Nature. 1989 Apr 13;338(6216):582-5
2538761
Mol Cell Endocrinol. 1994 Jul;103(1-2):157-63
7958392
Brain Res. 2003 Mar 28;967(1-2):285-9
12650990
Nature. 1997 Sep 25;389(6649):385-9
9311780
J Neurosci. 2003 Nov 19;23(33):10650-61
14627650
J Neurochem. 1996 Feb;66(2):685-91
8592140
Nat Neurosci. 2000 Jun;3(6):587-92
10816315
Trends Neurosci. 2004 Sep;27(9):569-75
15331240
Curr Top Med Chem. 2002 Aug;2(8):903-13
12171579
J Membr Biol. 1996 Nov;154(1):11-21
8881023
J Neurochem. 1991 Feb;56(2):713-5
1846404
Nature. 1997 Feb 27;385(6619):820-3
9039914
Brain Res Mol Brain Res. 1996 Jan;35(1-2):91-102
8717344
J Psychopharmacol. 2007 Jun;21(4):384-91
17092983
Curr Top Med Chem. 2002 Aug;2(8):833-9
12171574
J Neurosci. 2006 May 24;26(21):5673-83
16723524
J Biol Chem. 1997 Jun 27;272(26):16564-9
9195967
Mol Pharmacol. 2005 Sep;68(3):787-92
15939801
J Neurosci. 2001 May 1;21(9):3009-16
11312285
J Biol Chem. 2004 Oct 1;279(40):41422-35
15258161
Curr Opin Pharmacol. 2006 Feb;6(1):24-9
16359919
Physiol Rev. 2004 Jul;84(3):835-67
15269338
Pharmacol Ther. 2007 Oct;116(1):20-34
17531325
Nature. 1999 Oct 21;401(6755):796-800
10548105
Chembiochem. 2002 Nov 4;3(11):1042-52
12404628
J Physiol. 1997 Dec 1;505 ( Pt 2):299-306
9423173
Neuropharmacology. 2007 Jul;53(1):178-87
17585957
Trends Pharmacol Sci. 1996 Sep;17(9):319-23
8885697
Proc Natl Acad Sci U S A. 1990 Dec;87(24):9966-70
1702226
Trends Neurosci. 2005 Jun;28(6):284-9
15927683
Mol Pharmacol. 1996 Jul;50(1):119-27
8700104
Trends Biochem Sci. 2002 Jun;27(6):280-7
12069787
Eur J Neurosci. 2000 Oct;12(10):3575-82
11029627
J Neurosci. 2005 Nov 9;25(45):10462-8
16280584
Curr Pharm Des. 2005;11(15):1867-85
15974965
Pharmacol Rev. 1995 Jun;47(2):181-234
7568326
Nat Neurosci. 2007 Aug;10(8):953-62
17643119
J Neurochem. 2007 Nov;103(3):1258-71
17714454
Alcohol Clin Exp Res. 2001 Dec;25(12):1708-18
11781502
J Neurosci. 1994 Nov;14(11 Pt 2):7077-86
7525894
Proc Natl Acad Sci U S A. 2002 Jun 25;99(13):8980-5
12084936
J Comp Neurol. 1991 Jun 22;308(4):586-613
1650800
Nature. 2006 Mar 23;440(7083):448-55
16554804
J Biol Chem. 2003 Jan 10;278(2):712-7
12381728
J Comp Neurol. 1992 Dec 8;326(2):193-216
1336019
Nat Neurosci. 2007 Jan;10(1):40-8
17159992
Mol Pharmacol. 1998 Nov;54(5):928-33
9804628
Proc Natl Acad Sci U S A. 2006 May 30;103(22):8540-5
16698930
Neuropharmacology. 1996 Feb;35(2):137-45
8734481
Pharmacol Ther. 2006 Jan;109(1-2):12-32
15996746
Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):14439-44
14623958
J Neurosci. 2003 Sep 17;23(24):8608-17
13679430
J Neurosci. 2008 Jan 2;28(1):106-15
18171928
Neuropharmacology. 2002 Sep;43(4):695-700
12367615
J Neurosci. 1998 Apr 1;18(7):2449-57
9502805
Trends Neurosci. 1995 Dec;18(12):515-9
8638289
Nat Rev Neurosci. 2005 Mar;6(3):215-29
15738957
Curr Pharm Des. 2006;12(28):3615-30
17073663
Alcohol. 2007 May;41(3):201-9
17591543
Eur J Pharmacol. 2005 Dec 5;526(1-3):240-50
16253225
Neuroscience. 2003;119(4):933-43
12831854
J Biol Chem. 2004 Oct 15;279(42):43654-60
15304513
J Neurochem. 2005 Jul;94(2):482-90
15998298
J Physiol. 1999 Mar 15;515 ( Pt 3):711-27
10066899
Prog Neurobiol. 1993 Jan;40(1):1-61
8380934
J Neurosci. 2005 Jan 5;25(1):88-95
15634770
Neuroreport. 2000 Dec 18;11(18):4103-6
11192636
Prog Biophys Mol Biol. 2004 Oct;86(2):161-204
15288758
Nat Rev Neurosci. 2004 Sep;5(9):709-20
15322529
Mol Pharmacol. 1999 Sep;56(3):598-610
10462548
Nature. 1999 Jan 28;397(6717):359-63
9950429
J Neurosci. 1992 Mar;12(3):1040-62
1312131
Neuroscience. 2000;101(4):815-50
11113332
J Biol Chem. 1991 Dec 25;266(36):24778-84
1662216
J Physiol. 2006 Dec 15;577(Pt 3):841-56
17023503